Toward a biosignature for suicide

American Journal of Psychiatry

Volumn 171, Issue 12, 2014, Pages 1259-1277

  Oquendo, Maria A ^a   Sullivan, Gregory M ^a   Sudol, Katherin ^a   Baca Garcia, Enrique ^a   Stanley, Barbara H ^a   Sublette, M Elizabeth ^a   Mann, J John ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIOLOGICAL MARKER; DOPAMINE; GLUTAMIC ACID; NORADRENALIN; SEROTONIN;

BRAIN; GENE EXPRESSION REGULATION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; LOCUS CERULEUS; MENTAL STRESS; METABOLISM; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; SUICIDE;

BIOMARKERS; BRAIN; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; LOCUS COERULEUS; NEURONAL PLASTICITY; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; SEROTONIN; STRESS, PSYCHOLOGICAL; SUICIDE;

EID: 84914151062     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.14020194     Document Type: Review

References (173)

1. Centers for Disease Control and Prevention: Suicide and Self- Inflicted Injury. http://www.cdc.gov/nchs/fastats/suicide.htm.
2. World Health Organization: Suicide Prevention (SUPRE). http://www.who.int/mental-health/prevention/suicide/suicideprevent/en/.
3. Mann JJ, Waternaux C, Haas GL, Malone KM: Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999; 156:181-189.
4. Mann JJ, Arango V: Integration of neurobiology and psychopathology in a unified model of suicidal behavior. J Clin Psychopharmacol 1992; 12(suppl):2S-7S.
5. Biomarkers Definitions Working Group.: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69:89-95.
6. de Kloet ER, Joëls M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6:463-475.
7. Chrousos GP, Gold PW: The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 1992; 267:1244-1252.
8. McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87:873-904.
9. Arato M, Bánki CM, Bissette G, Nemeroff CB: Elevated CSF CRF in suicide victims. Biol Psychiatry 1989; 25:355-359.
10. Austin MC, Janosky JE, Murphy HA: Increased corticotropinreleasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 2003; 8:324-332.
11. Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bedard T, Anisman H: Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry 2006; 59:594-602.
12. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M: Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988; 45:577-579.
13. Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H: Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA (A) receptor subunits in frontal cortical brain region. J Neurosci 2004; 24:1478-1485.
14. Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ: Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 1992; 56:491-501.
15. Pandey GN, Rizavi HS, Ren X, Dwivedi Y, Palkovits M: Regionspecific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims. Psychoneuroendocrinology 2013; 38:2628-2639.
16. Lopez JF, Chalmers DT, Little KY, Watson SJ: AE Bennett Research Award: Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biol Psychiatry 1998; 43:547-573.
17. Herman JP, Adams D, Prewitt C: Regulatory changes in neuro endocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995; 61:180-190.
18. Herman JP, Watson SJ: Glucocorticoid regulation of stressinduced mineralocorticoid receptor gene transcription in vivo. Ann N Y Acad Sci 1994; 746:485-488.
19. Labonte B, Yerko V, Gross J, Mechawar N, Meaney MJ, Szyf M, Turecki G: Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biol Psychiatry 2012; 72: 41-48.
20. Jokinen J, Ouda J, Nordström P: Noradrenergic function and HPA axis dysregulation in suicidal behaviour. Psychoneuroendocrinology 2010; 35:1536-1542.
21. Dorovini-Zis K, Zis AP: Increased adrenal weight in victims of violent suicide. Am J Psychiatry 1987; 144:1214-1215.
22. Dumser T, Barocka A, Schubert E: Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol 1998; 19:72-76.
23. Szigethy E, Conwell Y, Forbes NT, Cox C, Caine ED: Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry 1994; 36:374-380.
24. Stein E, McCrank E, Schaefer B, Goyer R: Adrenal gland weight and suicide. Can J Psychiatry 1993; 38:563-566.
25. Supriyanto I, Sasada T, Fukutake M, Asano M, Ueno Y, Nagasaki Y, Shirakawa O, Hishimoto A: Association of FKBP5 gene haplotypes with completed suicide in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:252-256.
26. Yerevanian BI, Feusner JD, Koek RJ, Mintz J: The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 2004; 83:103-108.
27. Jokinen J, Carlborg A, Mårtensson B, Forslund K, Nordström AL, Nordström P: DST non-suppression predicts suicide after attempted suicide. Psychiatry Res 2007; 150:297-303.
28. Coryell W, Schlesser M: The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001; 158:748-753.
29. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP: Can biological tests assist prediction of suicide in mood disorders? Int J Neuro psychopharmacol 2006; 9:465-474.
30. Ordway GA, Widdowson PS, Smith KS, Halaris A: Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neuro chem 1994; 63:617-624.
31. Biegon A, Fieldust S: Reduced tyrosine hydro xylase immunoreactivity in locus coeruleus of suicide victims. Synapse 1992; 10:79-82.
32. Gross-Isseroff R, Dillon KA, Fieldust SJ, Biegon A: Auto radiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem: effect of suicide. Arch Gen Psychiatry 1990; 47:1049-1053.
33. Arango V, Ernsberger P, Sved AF, Mann JJ: Quantitative autoradiography of alpha 1- And alpha 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res 1993; 630:271-282.
34. Underwood MD, Mann JJ, Arango V: Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcohol Clin Exp Res 2004; 28(suppl):57S-69S.
35. González AM, Pascual J, Meana JJ, Barturen F, del Arco C, Pazos A, García-Sevilla JA: Auto radiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J Neuro chem 1994; 63:256-265.
36. De Paermentier F, Mauger JM, Lowther S, Crompton MR, Katona CL, Horton RW: Brain alpha-adrenoceptors in depressed suicides. Brain Res 1997; 757:60-68.
37. Fukutake M, Hishimoto A, Nishiguchi N, Nushida H, Ueno Y, Shirakawa O, Maeda K: Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog Neuro psychopharmacol Biol Psychiatry 2008; 32:1428-1433.
38. Mann JJ, Stanley M, McBride PA, McEwen BS: Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986; 43:954-959.
39. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ, Mann JJ: Auto radiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990; 47:1038-1047.
40. Biegon A, Israeli M: Regionally selective increases in beta adrenergic receptor density in the brains of suicide victims. Brain Res 1988; 442:199-203.
41. Little KY, Clark TB, Ranc J, Duncan GE: Beta-adrenergic receptor binding in frontal cortex from suicide victims. Biol Psychiatry 1993; 34:596-605.
42. De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW: Brain beta-adrenoceptor binding sites in anti depressant free depressed suicide victims. Brain Res 1990; 525:71-77.
43. De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW: Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment. Psychopharmacology (Berl) 1991; 105:283-288.
44. Baron BM, Ogden AM, Siegel BW, Stegeman J, Ursillo RC, Dudley MW: Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol 1988; 154:125-134.
45. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA: Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 1997; 17:8451-8458.
46. Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD: High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuro report 2002; 13:1195-1198.
47. Mann JJ, Stanley M: Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr Scand 1984; 69:135-139.
48. Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K: Association between catechol-O-methyl trans ferase functional polymorphism and male suicide completers. Neuro psychopharmacology 2004; 29:1374-1377.
49. Pivac N, Pregelj P, Nikolac M, Zupanc T, Nedic G, Muck Seler D, Videtic Paska A: The association between catechol-O-methyl trans ferase Val108/158Met polymorphism and suicide. Genes Brain Behav 2011; 10:565-569.
50. Arango V, Underwood MD, Mann JJ: Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry 1996; 39:112-120.
51. Du L, Merali Z, Poulter MO, Palkovits M, Faludi G, Anisman H: Catechol-O-methyl trans ferase Val158Met polymorphism and altered COMT gene expression in the prefrontal cortex of suicide brains. Prog Neuro psycho pharmacol Biol Psychiatry 2014; 50:178-183.
52. Ruud TE, Gundersen Y, Krohn CD, Sveen O, Aasen AO: Effects of infliximab and hydrocortisone on in vitro cytokine responses after stimulation with lipopolysaccharide. Surg Infect (Larchmt) 2013; 14:30-34.
53. Pace TW, Gaylord RI, Jarvis E, Girotti M, Spencer RL: Differential gluco corticoid effects on stress-induced gene expression in the paraventricular nucleus of the hypothalamus and ACTH secretion in the rat. Stress 2009; 12:400-411.
54. Raison CL, Miller AH: Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003; 54: 283-294.
55. Fragoso YD, Frota ER, Lopes JS, Noal JS, Giacomo MC, Gomes S, Gonçalves MV, da Gama PD, Finkelsztejn A: Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis. Clin Neuro pharmacol 2010; 33:312-316.
56. Zhu CB, Blakely RD, Hewlett WA: The pro inflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuro psychopharmacology 2006; 31: 2121-2131.
57. Ramamoorthy S, Ramamoorthy JD, Prasad PD, Bhat GK, Mahesh VB, Leibach FH, Ganapathy V: Regulation of the human serotonin transporter by interleukin-1 beta. Bio chem Bio phys Res Commun 1995; 216:560-567.
58. Mössner R, Heils A, Stöber G, Okladnova O, Daniel S, Lesch KP: Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int 1998; 33:251-254.
59. Mössner R, Daniel S, Schmitt A, Albert D, Lesch KP: Modulation of serotonin transporter function by interleukin-4. Life Sci 2001; 68:873-880.
60. Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, Conley RR, Dwivedi Y: Pro inflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 2012; 46:57-63.
61. Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K, Schnabel A, Möller HJ, Chen HH, Postolache TT: Elevated cytokine expression in the orbit ofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008; 117:198-206.
62. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG, Bogerts B: Immunological aspects in the neurobiology of suicide: elevated micro glial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 2008; 42:151-157.
63. Calder PC: n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83(suppl):1505S-1519S.
64. Huan M, Hamazaki K, Sun Y, Itomura M, Liu H, Kang W, Watanabe S, Terasawa K, Hamazaki T: Suicide attempt and n-3 fatty acid levels in red blood cells: A case control study in China. Biol Psychiatry 2004; 56:490-496.
65. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ: Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006; 163:1100-1102.
66. Lewis MD, Hibbeln JR, Johnson JE, Lin YH, Hyun DY, Loewke JD: Suicide deaths of active-duty US military and omega-3 fatty acid status: A case-control comparison. J Clin Psychiatry 2011; 72:1585-1590.
67. McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Roberts RC, Conley RR, Pandey GN: Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims. Prostaglandins Leukot Essent Fatty Acids 2009; 80:19-26.
68. Lalovic A, Levy E, Canetti L, Sequeira A, Montoudis A, Turecki G: Fatty acid composition in postmortem brains of people who completed suicide. J Psychiatry Neurosci 2007; 32:363-370.
69. Poudel-Tandukar K, Nanri A, Iwasaki M, Mizoue T, Matsushita Y, Takahashi Y, Noda M, Inoue M, Tsugane S; Japan Public Health Center-based Prospective Study Group: Long chain n-3 fatty acids intake, fish consumption, and suicide in a cohort of Japanese men and women: The Japan Public Health Center based (JPHC) prospective study. J Affect Disord 2011; 129: 282-288.
70. Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF: Role of endogenous opioid system in the regulation of the stress response. Prog Neuro psychopharmacol Biol Psychiatry 2001; 25:729-741.
71. Hishimoto A, Cui H, Mouri K, Nushida H, Ueno Y, Maeda K, Shirakawa O: A functional polymorphism of the m-opioid receptor gene is associated with completed suicides. J Neural Transm 2008; 115:531-536.
72. Gabilondo AM, Meana JJ, García-Sevilla JA: Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res 1995; 682:245-250.
73. González-Maeso J, Rodríguez-Puertas R, Meana JJ, García-Sevilla JA, Guimon J: Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: Selective super sensitivity of alpha(2A)-adrenoceptors. Mol Psychiatry 2002; 7:755-767.
74. Zalsman G, Molcho A, Huang Y, Dwork A, Li S, Mann JJ: Postmortem mu-opioid receptor binding in suicide victims and controls. J Neural Transm 2005; 112:949-954.
75. Gross-Isseroff R, Dillon KA, Israeli M, Biegon A: Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res 1990; 530:312-316.
76. Escribá PV, Ozaita A, García-Sevilla JA: Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors, and mu-opioid receptors in the brains of suicide victims. Neuro psychopharmacology 2004; 29:1512-1521.
77. Hurd YL, Herman MM, Hyde TM, Bigelow LB, Weinberger DR, Kleinman JE: Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects. Mol Psychiatry 1997; 2:495-500.
78. Scarone S, Gambini O, Calabrese G, Sacerdote P, Bruni M, Carucci M, Panerai AE: Asymmetrical distribution of beta-endorphin in cerebral hemispheres of suicides: preliminary data. Psychiatry Res 1990; 32:159-166.
79. Frazer A, Hensler JG: Serotonin receptors, in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Edited by Siegel GJ, Agranoff BW, Albers RW, Price DL. Philadelphia, Lippincott-Raven, 1999.
80. Fitzpatrick PF: Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 1999; 68:355-381.
81. Martínez A, Knappskog PM, Haavik J: A structural approach into human tryptophan hydro xylase and its implications for the regulation of serotonin biosynthesis. Curr Med Chem 2001; 8:1077-1091.
82. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M: Synthesis of serotonin by a second tryptophan hydro xylase isoform. Science 2003; 299:76.
83. Dube F, Amireault P: Local serotonergic signaling in mammalian follicles, oocytes, and early embryos. Life Sci 2007; 81:1627-1637.
84. Perroud N, Neidhart E, Petit B, Vessaz M, Laforge T, Relecom C, La Harpe R, Malafosse A, Guipponi M: Simultaneous analysis of serotonin transporter, tryptophan hydro xylase 1 and 2 gene expression in the ventral prefrontal cortex of suicide victims. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:909-918.
85. Bach-Mizrachi H, Underwood MD, Kassir SA, Bakalian MJ, Sibille E, Tamir H, Mann JJ, Arango V: Neuronal tryptophan hydro xylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuro psychopharmacology 2006; 31:814-824.
86. Boldrini M, Underwood MD, Mann JJ, Arango V: More tryptophan hydro xylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 2005; 1041:19-28.
87. De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH: Gene expression of tryptophan hydro xylase 2 in post-mortem brain of suicide subjects. Int J Neuro psychopharmacol 2006; 9:21-25.
88. Bach-Mizrachi H, Underwood MD, Tin A, Ellis SP, Mann JJ, Arango V: Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol Psychiatry 2008; 13:507-513.
89. Matthews PR, Harrison PJ: A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide. J Affect Disord 2012; 137:125-134.
90. Bach H, Huang YY, Underwood MD, Dwork AJ, Mann JJ, Arango V: Elevated serotonin and 5-HIAA in the brainstem and lower serotonin turnover in the prefrontal cortex of suicides. Synapse 2014; 68:127-130.
91. Zill P, Büttner A, Eisenmenger W, Möller HJ, Bondy B, Ackenheil M: Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 2004; 56:581-586.
92. Lopez de Lara C, Brezo J, Rouleau G, Lesage A, Dumont M, Alda M, Benkelfat C, Turecki G: Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry 2007; 62:72-80.
93. Stefulj J, Mokrovic G, Hranilovic D, Bordukalo-Niksic T, Bakula M, Kubat M, Jernej B: Functional promoter polymorphism of the neuronal isoform of tryptophan hydroxylase (Tph2) in suicide. Psychiatry Res 2011; 186:446-447.
94. Mouri K, Hishimoto A, Fukutake M, Shiroiwa K, Asano M, Nagasaki Y, Ueno Y, Shirakawa O, Nishiguchi N, Maeda K: TPH2 is not a susceptibility gene for suicide in Japanese population. Prog Neuro psychopharmacol Biol Psychiatry 2009; 33:1546-1550.
95. Arango V, Underwood MD, Gubbi AV, Mann JJ: Localized alterations in pre- And postsynaptic serotonin binding sites in the ventro lateral prefrontal cortex of suicide victims. Brain Res 1995; 688:121-133.
96. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V: A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000; 57:729-738.
97. Stanley M, Virgilio J, Gershon S: Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982; 216:1337-1339.
98. Rosel P, Arranz B, Vallejo J, Oros M, Menchon JM, Alvarez P, Navarro MA: High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains. J Neural Transm 1997; 104:921-929.
99. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ: Serotonin 1A receptors, serotonin transporter binding, and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuro psychopharmacology 2001; 25:892-903.
100. Gross-Isseroff R, Israeli M, Biegon A: Auto radiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch Gen Psychiatry 1989; 46:237-241.
101. Lopez de Lara C, Dumais A, Rouleau G, Lesage A, Dumont M, Chawky N, Alda M, Benkelfat C, Turecki G: STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol Psychiatry 2006; 59: 114-120.
102. Buttenschøn HN, Flint TJ, Foldager L, Qin P, Christoffersen S, Hansen NF, Kristensen IB, Mortensen PB, Børglum AD, Mors O: An association study of suicide and candidate genes in the serotonergic system. J Affect Disord 2013; 148:291-298.
103. Jernej B, Stefulj J, Hranilovic D, Balija M, Skavic J, Kubat M: Intronic polymorphism of tryptophan hydroxylase and serotonin transporter: Indication for combined effect in predisposition to suicide. J Neural Transm 2004; 111:733-738.
104. Zupanc T, Pregelj P, Tomori M, Komel R, Paska AV: No association between polymorphisms in four serotonin receptor genes, serotonin transporter gene, and alcohol-related suicide. Psychiatr Danub 2010; 22:522-527.
105. Hranilovic D, Stefulj J, Furac I, Kubat M, Balija M, Jernej B: Serotonin transporter gene promoter (5-HTTLPR) and intron 2 (VNTR) polymorphisms in Croatian suicide victims. Biol Psychiatry 2003; 54:884-889.
106. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G: Increase in serotonin-1A auto receptors in the midbrain of suicide victims with major depression: postmortem evidence for decreased serotonin activity. J Neurosci 1998; 18: 7394-7401.
107. Boldrini M, Underwood MD, Mann JJ, Arango V: Serotonin-1A auto receptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res 2008; 42:433-442.
108. Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Mann JJ, Arango V: Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int J Neuro psychopharmacol 2012; 15:435-447.
109. Arora RC, Meltzer HY: Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989; 146:730-736.
110. Stanley M, Mann JJ: Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983; 1:214-216.
111. Turecki G, Brière R, Dewar K, Antonetti T, Lesage AD, Seguin M, Chawky N, Vanier C, Alda M, Joober R, Benkelfat C, Rouleau GA: Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999; 156:1456-1458.
112. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J, Schatzberg AF, Watson SJ, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP: Gene expression changes in the prefrontal cortex, anterior cingulate cortex, and nucleus accumbens of mood disorders subjects that committed suicide. PLoS ONE 2012; 7:e35367.
113. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Faludi G, Sarosi A, Palkovits M: Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neuro chem Res 2006; 31:167-176.
114. Zouk H, McGirr A, Lebel V, Benkelfat C, Rouleau G, Turecki G: The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide. Am J Med Genet B Neuro psychiatr Genet 2007; 144B:996-1002.
115. Azenha D, Alves M, Matos R, Santa JF, Silva B, Cordeiro C, Vieira DN, Ambrosio AM: Male specific association between the 5-HTR6 gene 267C/T SNP and suicide in the Portuguese population. Neurosci Lett 2009; 466:128-130.
116. Videtic A, Peternelj TT, Zupanc T, Balazic J, Komel R: Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav 2009; 8:541-545.
117. Turecki G, Sequeira A, Gingras Y, SeguinM, Lesage A, Tousignant M, Chawky N, Vanier C, Lipp O, Benkelfat C, Rouleau GA: Suicide and serotonin: Study of variation at seven serotonin receptor genes in suicide completers. Am J Med Genet B Neuropsychiatr Genet 2003; 118B:36-40.
118. Crawford J, Sutherland GR, Goldney RD: No evidence for association of 5-HT2A receptor polymorphism with suicide. Am J Med Genet 2000; 96:879-880.
119. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Maeda K: Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J Psychiatr Res 2001; 35:173-176.
120. Galfalvy H, Zalsman G, Huang YY, Murphy L, Rosoklija G, Dwork AJ, Haghighi F, Arango V, Mann JJ: A pilot genome wide association and gene expression array study of suicide with and without major depression. World J Biol Psychiatry 2013; 14:574-582.
121. Jokinen J, Nordström AL, Nordström P: Cerebrospinal fluid monoamine metabolites and suicide. Nord J Psychiatry 2009; 63:276-279.
122. Asberg M, Träskman L, Thoren P: 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33:1193-1197.
123. Träskman L, Asberg M, Bertilsson L, Sjöstrand L: Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981; 38:631-636.
124. Jokinen J, Nordström AL, Nordström P: CSF 5-HIAA and DST non-suppression: orthogonal biologic risk factors for suicide in male mood disorder inpatients. Psychiatry Res 2009; 165:96-102.
125. Owen F, Chambers DR, Cooper SJ, Crow TJ, Johnson JA, Lofthouse R, Poulter M: Serotonergic mechanisms in brains of suicide victims. Brain Res 1986; 362:185-188.
126. Cheetham SC, Crompton MR, Czudek C, Horton RW, Katona CL, Reynolds GP: Serotonin concentrations and turnover in brains of depressed suicides. Brain Res 1989; 502:332-340.
127. Nagatsu T: Genes for human catecholamine-synthesizing enzymes. Neuro sci Res 1991; 12:315-345.
128. Sokoloff P, Schwartz JC: Novel dopamine receptors half a decade later. Trends Pharmacol Sci 1995; 16:270-275.
129. Pitchot W, Reggers J, Pinto E, Hansenne M, Fuchs S, Pirard S, Ansseau M: Reduced dopaminergic activity in depressed suicides. Psycho neuro endocrinology 2001; 26:331-335.
130. Schroeder C, Tank J, Goldstein DS, Stoeter M, Haertter S, Luft FC, Jordan J: Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans. Clin Pharmacol Ther 2004; 76:480-489.
131. Allard P, Norlen M: Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims. J Neural Transm 1997; 104:1353-1360.
132. Allard P, Norlen M: Caudate nucleus dopamine D(2) receptors in depressed suicide victims. Neuro psychobiology 2001; 44:70-73.
133. Bowden C, Theodorou AE, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW: Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res 1997; 752:227-233.
134. Ohmori T, Arora RC, Meltzer HY: Serotonergic measures in suicide brain: The concentration of 5-HIAA, HVA, and tryptophan in frontal cortex of suicide victims. Biol Psychiatry 1992; 32:57-71.
135. Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW: Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 1997; 769:135-140.
136. Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H: GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 2002; 213:1-47.
137. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ: International Union of Pharmacology. XV. Subtypes of gamma-amino butyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998; 50:291-313.
138. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, Enna SJ: International Union of Pharmacology. XXXIII. Mammalian gamma-amino butyric acid (B) receptors: Structure and function. Pharmacol Rev 2002; 54:247-264.
139. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, Benkelfat C, Rouleau GA, Mechawar N, Turecki G: Global brain gene expression analysis links glutamatergic and GABA ergic alterations to suicide and major depression. PLoS ONE 2009; 4:e6585.
140. Poulter MO, Du L, Zhurov V, Palkovits M, Faludi G, Merali Z, Anisman H: Altered Organization of GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain. Front Mol Neurosci 2010; 3:3.
141. Zhu H, Karolewicz B, Nail E, Stockmeier CA, Szebeni K, Ordway GA: Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide. Brain Res 2006; 1125:138-146.
142. Poulter MO, Du L, Weaver IC, Palkovits M, Faludi G, Merali Z, Szyf M, Anisman H: GABAA receptor promoter hyper methylation in suicide brain: Implications for the involvement of epigenetic processes. Biol Psychiatry 2008; 64:645-652.
143. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, ffrench- Mullen J, Turecki G: Altered expression of genes involved in ATP biosynthesis and GABA ergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 2009; 14:175-189.
144. Cross JA, Cheetham SC, Crompton MR, Katona CL, Horton RW: Brain GABAB binding sites in depressed suicide victims. Psychiatry Res 1988; 26:119-129.
145. Tamminga CA: Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 1998; 12:21-36.
146. Korpi ER, Kleinman JE, Wyatt RJ: GABA concentrations in forebrain areas of suicide victims. Biol Psychiatry 1988; 23:109- 114.
147. Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, Kleinman JE: Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse 1997; 27:168-176.
148. Palmer AM, Burns MA, Arango V, Mann JJ: Similar effects of glycine, zinc, and an oxidizing agent on [3H]dizocilpine binding to the N-methyl-D-aspartate receptor in neocortical tissue from suicide victims and controls. J Neural Transm 1994; 96: 1-8.
149. Freed WJ, Dillon-Carter O, Kleinman JE: Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: Increases in caudate nucleus associated with suicide. Exp Neurol 1993; 121:48-56.
150. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, Jones EG: Altered cortical glutamatergic and GABA ergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102:15653-15658.
151. Nowak G, Ordway GA, Paul IA: Alterations in the N-methyl-Daspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 1995; 675:157-164.
152. Holemans S, De Paermentier F, Horton RW, Crompton MR, Katona CL, Maloteaux JM: NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides. Brain Res 1993; 616:138-143.
153. Thoenen H: Neuro trophins and activity-dependent plasticity. Prog Brain Res 2000; 128:183-191.
154. Cooper JD, Skepper JN, Berzaghi MD, Lindholm D, Sofroniew MV: Delayed death of septal cholinergic neurons after excitotoxic ablation of hippocampal neurons during early postnatal development in the rat. Exp Neurol 1996; 139:143-155.
155. Duman RS, Monteggia LM: A neuro trophic model for stress related mood disorders. Biol Psychiatry 2006; 59:1116-1127.
156. Katz LC, Shatz CJ: Synaptic activity and the construction of cortical circuits. Science 1996; 274:1133-1138.
157. Castren E, Rantamäki T: The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010; 70:289-297.
158. Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G: Glutamatergic modulators: The future of treating mood disorders? Harv Rev Psychiatry 2010; 18:293- 303.
159. Rajkowska G: Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann N Y Acad Sci 1997; 836:253-268.
160. Boldrini M, Santiago AN, Hen R, Dwork AJ, Rosoklija GB, Tamir H, Arango V, John Mann J: Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuro psychopharmacology 2013; 38:1068-1077.
161. Altshuler LL, Casanova MF, Goldberg TE, Kleinman JE: The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. Arch Gen Psychiatry 1990; 47:1029-1034.
162. Pandey GN, Ren X, Rizavi HS, Conley RR, Roberts RC, Dwivedi Y: Brain-derived neuro trophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuro psychopharmacol 2008; 11:1047-1061.
163. Maussion G, Yang J, Yerko V, Barker P, Mechawar N, Ernst C, Turecki G: Regulation of a truncated form of tropomyosinrelated kinase B (TrkB) by Hsa-miR-185∗ in frontal cortex of suicide completers. PLoS ONE 2012; 7:e39301.
164. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Altered gene expression of brain-derived neuro trophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60: 804-815.
165. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R: Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005; 136:29-37.
166. Dwivedi Y, Rizavi HS, Zhang H, Mondal AC, Roberts RC, Conley RR, Pandey GN: Neuro trophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry 2009; 65:319-328.
167. Dwivedi Y, Mondal AC, Rizavi HS, Conley RR: Suicide brain is associated with decreased expression of neuro trophins. Biol Psychiatry 2005; 58:315-324.
168. Pregelj P, Nedic G, Paska AV, Zupanc T, Nikolac M, Balazic J, Tomori M, Komel R, Seler DM, Pivac N: The association between brain-derived neuro trophic factor polymorphism (BDNF Val66Met) and suicide. J Affect Disord 2011; 128:287-290.
169. Keller S, Sarchiapone M, Zarrilli F, Tomaiuolo R, Carli V, Angrisano T, Videtic A, Amato F, Pero R, di Giannantonio M, Iosue M, Lembo F, Castaldo G, Chiariotti L: TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. J Affect Disord 2011; 135:400-404.
170. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, Sacchetti S, Lembo F, Angiolillo A, Jovanovic N, Pisanti F, Tomaiuolo R, Monticelli A, Balazic J, Roy A, Marusic A, Cocozza S, Fusco A, Bruni CB, Castaldo G, Chiariotti L: Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010; 67:258-267.
171. Bondy B, Erfurth A, de Jonge S, Krüger M, Meyer H: Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry 2000; 5:193-195.
172. Videtic A, Zupanc T, Pregelj P, Balazic J, Tomori M, Komel R: Suicide, stress, and serotonin receptor 1A promoter polymorphism -1019C.G in Slovenian suicide victims. Eur Arch Psychiatry Clin Neurosci 2009; 259:234-238.
173. Ratta-apha W, Hishimoto A, Mouri K, Shiroiwa K, Sasada T, Yoshida M, Okazaki S, Supriyanto I, Asano M, Ueno Y, Shirakawa O, Sora I: Haplotype analysis of the DISC1 Ser704Cys variant in Japanese suicide completers. Psychiatry Res 2014; 215: 249-251.